Reply to Letters to the Editor

Ana Vega¹, Emily L Heil^{2

3}, Alison Blackman^{2

4}, Mary Banoub³, J Kristie Johnson^{3

5}, Surbhi Leekha^{3

5}, Kimberly C Claeys^{2

3}

Affiliations

¹ Department of Pharmacy, Jackson Health System, Miami, Florida, USA.
² Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
³ Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA.
⁴ Department of Pharmacy, Boston Medical Center, Boston, Massachusetts, USA.
⁵ University of Maryland School of Medicine, Baltimore, Maryland, USA.

Comment

Ana Vega et al. Pharmacotherapy. 2020 Sep.

. 2020 Sep;40(9):985-986.

doi: 10.1002/phar.2454.

Ana Vega¹, Emily L Heil^{2

3}, Alison Blackman^{2

4}, Mary Banoub³, J Kristie Johnson^{3

5}, Surbhi Leekha^{3

5}, Kimberly C Claeys^{2

3}

¹ Department of Pharmacy, Jackson Health System, Miami, Florida, USA.
² Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
³ Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA.
⁴ Department of Pharmacy, Boston Medical Center, Boston, Massachusetts, USA.
⁵ University of Maryland School of Medicine, Baltimore, Maryland, USA.

No abstract available

Comment on

Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.
Vega AD, Heil EL, Blackman AL, Banoub M, Kristie Johnson J, Leekha S, Claeys KC. Vega AD, et al. Pharmacotherapy. 2020 May;40(5):398-407. doi: 10.1002/phar.2393. Epub 2020 Apr 21. Pharmacotherapy. 2020. PMID: 32246501
Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection".
Ito H. Ito H. Pharmacotherapy. 2020 Sep;40(9):984. doi: 10.1002/phar.2455. Pharmacotherapy. 2020. PMID: 33112453 No abstract available.